3B BlackBio Dx
3B BlackBio Dx Share Price Chart
3B BlackBio Dx last traded at ₹1,612.10 (2026-10-13). Over the past month the stock moved +10.3%, three months the stock moved +34.5%, year the stock moved +16.8%. Its closing range over 52 weeks is ₹1,138.50 – ₹1,703.90, with the latest close 5.4% below the high.
Closing prices up to 2026-10-13.
About 3B BlackBio Dx
Incorporated in 2011, 3B BlackBio Dx Ltd manufactures and exports PCR based Molecular Diagnostic kits, PCR Enzymes & PCR Reagents, and agrochemical-based products[1]
Business Segments[1][2] A) Diagnostics Business (81% of FY23 revenue) 3BDL is part of an Indo-Spanish JV and was formed by amalgamation with its parent company Kilpest India Limited. Company is an ISO 13485:2016 certified, GMP-compliant biotech R&D organization and is engaged in the design, development, manufacturing, and commercialization of Rapid tests, PCR-based Molecular Diagnostic kits, PCR Enzymes & PCR Reagents, NGS-based Molecular Diagnostic Kit
Fundamentals
Quarterly Results
In the latest quarter (Jun 2026), 3B BlackBio Dx reported sales of ₹33.49 crore (+50.7%) and net profit of ₹8.98 crore (-29.0%), compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Jun 2026 | 33.49 | 8.52 | 25.44 | 8.98 | 11.10 |
| Mar 2026 | 35.43 | 8.49 | 23.96 | 9.81 | 11.14 |
| Dec 2025 | 50.35 | 21.72 | 43.14 | 22.44 | 25.32 |
| Sep 2025 | 33.90 | 14.73 | 43.45 | 15.04 | 17.14 |
| Jun 2025 | 22.23 | 11.83 | 53.22 | 12.65 | 14.67 |
| Mar 2025 | 22.50 | 7.92 | 35.20 | 8.04 | 9.79 |
| Dec 2024 | 25.39 | 15.07 | 59.35 | 13.49 | 15.61 |
| Sep 2024 | 29.15 | 16.17 | 55.47 | 14.87 | 17.07 |
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +52.0% | +43.7% | -2.2% | +14.4% | +16.3% | +98.3% | +57.5% | +50.7% |
| Operating profit growth | +107.6% | +69.9% | -19.8% | +8.0% | -8.9% | +44.1% | +7.2% | -28.0% |
| Net profit growth | +96.2% | +58.5% | -8.5% | +11.9% | +1.1% | +66.3% | +22.0% | -29.0% |
| EPS growth | +63.2% | +53.6% | -5.2% | +13.1% | +0.4% | +62.2% | +13.8% | -24.3% |
| OPM % | 55.5% | 59.4% | 35.2% | 53.2% | 43.5% | 43.1% | 24.0% | 25.4% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Annual Financials
In the latest year (Mar 2026), 3B BlackBio Dx reported sales of ₹142.00 crore (+47.9%) and net profit of ₹60.00 crore (+25.0%), compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 142.00 | 57.00 | 40.00 | 60.00 | 68.27 |
| Mar 2025 | 96.00 | 50.00 | 52.00 | 48.00 | 55.57 |
| Mar 2024 | 74.00 | 33.00 | 44.00 | 32.00 | 37.40 |
| Mar 2023 | 62.00 | 29.00 | 47.00 | 26.00 | 34.55 |
| Mar 2022 | 81.00 | 37.00 | 46.00 | 32.00 | 42.89 |
| Mar 2021 | 227.00 | 150.00 | 66.00 | 114.00 | 151.66 |
| Mar 2020 | 29.00 | 9.00 | 32.00 | 8.00 | 10.24 |
| Mar 2019 | 23.00 | 7.00 | 31.00 | 5.00 | 8.18 |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +0.0% | +26.1% | +682.8% | -64.3% | -23.5% | +19.4% | +29.7% | +47.9% |
| Operating profit growth | +40.0% | +28.6% | +1566.7% | -75.3% | -21.6% | +13.8% | +51.5% | +14.0% |
| Net profit growth | +66.7% | +60.0% | +1325.0% | -71.9% | -18.8% | +23.1% | +50.0% | +25.0% |
| EPS growth | +52.9% | +25.2% | +1381.1% | -71.7% | -19.4% | +8.2% | +48.6% | +22.9% |
| OPM % | 31.0% | 32.0% | 66.0% | 46.0% | 47.0% | 44.0% | 52.0% | 40.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Shareholding
AI Analysis
No AI analysis generated yet for 3B BlackBio Dx.
Get Free AI Stock Analysis FREE →Latest News
-
3B BlackBio Dx FY26 PAT at ₹59.92 crore, declares ₹5 dividend - scanx.trade
-
3B BlackBio Dx schedules one-on-one investor call for September 11 - scanx.trade
-
3B BlackBio Dx to host investor call with Param Capital on Aug 29 - scanx.trade
Frequently Asked Questions
What is the share price of 3B BlackBio Dx today?
3B BlackBio Dx shares were last quoted at ₹1,612.10 (+2.3% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
What is the P/E ratio of 3B BlackBio Dx?
3B BlackBio Dx has a price-to-earnings (P/E) ratio of 24.43 and a price-to-book (P/B) ratio of 4.07. The industry P/E is 34.96.
What is the 52-week high and low of 3B BlackBio Dx?
The 52-week high of 3B BlackBio Dx is ₹1,750.00 and the 52-week low is ₹1,083.50.
What is the market cap of 3B BlackBio Dx?
The market capitalisation of 3B BlackBio Dx is about ₹1,356.83 crore.
How did 3B BlackBio Dx perform in its latest quarterly results?
In the latest quarter (Jun 2026), 3B BlackBio Dx reported sales of ₹33.49 crore (+50.7%) and net profit of ₹8.98 crore (-29.0%), compared with the same quarter last year.
Is 3B BlackBio Dx a good stock to buy?
This page is for information and is not investment advice. As per the data shown here, 3B BlackBio Dx has a 3-year ROE of 18.00%, 3-year profit growth of 31.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
What is the promoter holding in 3B BlackBio Dx?
Promoters hold about 40.96% of 3B BlackBio Dx.
Which sector does 3B BlackBio Dx belong to?
3B BlackBio Dx belongs to the Pesticides & Agrochemicals sector.
Other Pesticides & Agrochemicals stocks
- PI Industries
- SUMITOMO CHEMICAL INDIA LIMITE
- Bayer CropScience
- Fine Organics Industries
- BASF India
- Sharda Cropchem
- UPL PP
- Dhanuka Agritech
All Pesticides & Agrochemicals stocks · Browse all stocks A–Z